What are the differences between 70% liposomal NMN and regular NMN?
The core difference between 70% liposomal NMN and regular NMN lies in the dosage form technology and absorption efficiency, rather than the chemical components themselves. While they are identical in molecular structure and basic efficacy, they differ significantly in their absorption and utilization within the body.
1. Differences in composition and structure
| Parameter | Regular NMN | 70% Liposome NMN |
|---|---|---|
| Core Components | NMN (β-Nicotinamide Mononucleotide) | NMN + Phospholipids (e.g., lecithin) |
| Physical Form | Regular powder or capsule | NMN encapsulated in phospholipid bilayer vesicles |
| NMN Content | Typically >90% | 70% (remainder is lipid carrier) |
Chemical Nature: The NMN molecules in 70% liposomal NMN are identical to those in regular NMN (CAS number 1094-61-7), the difference being whether or not liposomal technology is used for encapsulation.
2. Differences in Absorption Mechanisms
This is the most crucial difference between the two.
Absorption Pathway of Regular NMN:
Oral NMN is primarily absorbed by the body through the following pathways:
- Transporter-dependent absorption: NMN requires a transporter protein called Slc12a8 on the small intestinal wall to enter cells. This transporter protein has limited carrying capacity and easily reaches saturation; it can be understood as a channel with limited passage.
- Gastric acid degradation: The highly acidic environment of the stomach (pH 1.5-3.5) causes some NMN to be broken down before reaching the small intestine. Studies show that after 4 hours of treatment in simulated gastric juice, ordinary NMN is almost completely degraded.
- Rapid metabolism: After oral administration, the blood concentration of NMN rapidly reaches its peak within 30-45 minutes, then declines rapidly, with the overall duration of action lasting approximately 2-4 hours.
Absorption Pathway of Liposome NMN:
Liposome NMN encapsulates NMN within tiny vesicles (approximately 100-200 nm in diameter) composed of a phospholipid bilayer. Its absorption mechanism differs fundamentally from that of ordinary NMN:
- Physical Protection: The phospholipid shell effectively protects NMN from degradation by gastric acid and digestive enzymes. After treatment in simulated gastric juice (pH 2.0) for 4 hours, the retention rate of liposomal NMN still exceeds 80%.
- Multiple Absorption Pathways:
1)Lymphatic Absorption: Liposomes can be absorbed through the lymphatic system, bypassing the first-pass metabolism in the liver.
2)Membrane Fusion Mechanism: The structure of liposomes is highly similar to that of cell membranes (both are composed of a phospholipid bilayer), allowing direct fusion with the cell membrane and delivery of NMN into the cell interior without relying on transport proteins.
3)Endocytosis: Cells can take in intact liposomes via endocytosis, followed by enzymatic decomposition to release NMN.
- Sustained-Release Characteristics: Liposome NMN exhibits a smoother and more sustained release curve, with peak plasma release time extended to 60-120 minutes, and an overall duration of action lasting 8-12 hours.
- Scientific Principle: Dr. Christopher Shade, founder of Quicksilver Scientific, points out that research has found that the natural mechanism for transporting NMN between human cells relies on small vesicles similar to liposomes. Therefore, the design of liposomal NMN is essentially to mimic the body's own NMN transport mechanism.
3. Differences in Bioavailability
| Parameter | Regular NMN | 70% Liposome NMN |
|---|---|---|
| Thermal Stability | Complete degradation at 80°C within 12 hours | Significantly improved, phospholipid layer provides physical protection |
| Acid Resistance | Easily degraded in gastric acid | >80% remains intact after 4 hours in simulated gastric fluid |
| Recommended Storage | Sealed, room temperature, away from light and moisture | Refrigerated at 2-8°C for long-term storage preferred |
Clinical data reference: A 4-week double-blind controlled trial showed that in the group that took 350 mg of liposomal NMN daily, the blood NAD+ level increased from 28.6 µM at baseline to 52.5 µM, an increase of 84%, and remained above baseline 4 weeks after stopping the drug.
4. Stability and Storage Differences
| Parameter | Regular NMN | Liposome NMN |
|---|---|---|
| Clinical Evidence | Extensive, all major human trials use regular NMN | Emerging, promising results |
| Onset of Action | Rapid, detectable in plasma within minutes | Gradual, sustained release |
| Key Advantage | Well-documented safety and efficacy | Higher NAD+ elevation, longer duration, potentially lower effective dose |
5. Differences in Efficacy
Advantages of Regular NMN
- Strong Clinical Evidence: All major human clinical trials have used regular NMN, validating its effectiveness in improving insulin sensitivity and physical performance.
- Rapid Onset of Action: NMN is detectable in plasma within minutes of oral administration.
Advantages of Liposome NMN
- Higher NAD+ Boost: Studies show it produces "significantly more" NAD+ than regular NMN.
- Longer-Lasting Effect: Sustained-release properties support 24/7 activation of Sirtuins longevity proteins.
- Lower Effective Dosage: Due to higher absorption rates, the same effect may be achieved with a smaller dose.
Summary
Regular NMN is a reliable dosage form with strong clinical validation, offering low cost and robust evidence. 70% liposomal NMN, through phospholipid encapsulation technology, theoretically achieves higher absorption efficiency, better stability, and a longer-lasting NAD+ boost. The choice between the two should be based on a comprehensive consideration of budget, user experience, and expected efficacy.
